Clinical Pharmacology Perspectives for Adoptive Cell Therapies in Oncology

Adoptive cell therapies (ACTs) have shown transformative efficacy in oncology with five US Food and Drug Administration (FDA) approvals for chimeric antigen receptor (CAR) T‐cell therapies in hematological malignancies, and promising activity for T cell receptor T‐cell therapies in both liquid and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Weize, Li, Junyi, Liao, Michael Z., Liu, Stephanie N., Yu, Jiajie, Jing, Jing, Kotani, Naoki, Kamen, Lynn, Guelman, Sebastian, Miles, Dale R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786613/
https://www.ncbi.nlm.nih.gov/pubmed/34888856
http://dx.doi.org/10.1002/cpt.2509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786613/
https://www.ncbi.nlm.nih.gov/pubmed/34888856
http://dx.doi.org/10.1002/cpt.2509

Ejemplares similares